Literature DB >> 9285783

The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes.

F Corbin1, M Bouillon, A Fortin, S Morin, F Rousseau, E W Khandjian.   

Abstract

The fragile X syndrome results from a transcriptional silencing of the FMR1 gene and the absence of its encoded protein. FMRP is a cytoplasmic RNA-binding protein, whose specific cellular function is still unknown. We present evidence that virtually all detectable cytoplasmic FMRP in mouse NIH 3T3 and human HeLa cells is found strictly in association with mRNA in actively translating polyribosomes. Furthermore, FMRP released from polyribosomes is associated with ribonucleoprotein complexes with sedimentation coefficients of 60-70S and selection on oligo(dT)-cellulose reveals that this association is specific to poly(A)-containing mRNPs. This association with actively translating polyribosomes is not affected by alteration of translational processes induced by serum stimulation and starvation in NIH 3T3 cells, suggesting that FMR1 expression is not cell cycle regulated and that FMRP might have a house-keeping function. FXR2 protein, which is closely related to FMRP, is also detected associated with mRNPs in translating polyribosomes. The results strongly suggest that FMRP might be a mRNA chaperone interacting with mRNP complexes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285783     DOI: 10.1093/hmg/6.9.1465

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  80 in total

Review 1.  Candidate RNA-binding proteins regulating extrasomatic mRNA targeting and translation in mammalian neurons.

Authors:  Stefan Kindler; Michaela Monshausen
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

2.  A receptor for activated C kinase is part of messenger ribonucleoprotein complexes associated with polyA-mRNAs in neurons.

Authors:  Frank Angenstein; Anne M Evans; Robert E Settlage; Stewart T Moran; Shuo-Chien Ling; Anna Y Klintsova; Jeffrey Shabanowitz; Donald F Hunt; William T Greenough
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

3.  Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers.

Authors:  Deborah Hall; Flora Tassone; Olga Klepitskaya; Maureen Leehey
Journal:  Mov Disord       Date:  2011-12-11       Impact factor: 10.338

4.  In vivo association of the stability control protein alphaCP with actively translating mRNAs.

Authors:  Xinjun Ji; Jian Kong; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

Review 5.  Cytoplasmic RNA-binding proteins and the control of complex brain function.

Authors:  Jennifer C Darnell; Joel D Richter
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

6.  Poly(ADP-ribose) glycohydrolase is a component of the FMRP-associated messenger ribonucleoparticles.

Authors:  Jean-Philippe Gagné; Marie-Eve Bonicalzi; Pierre Gagné; Marie-Eve Ouellet; Michael J Hendzel; Guy G Poirier
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

Review 7.  RNA transport and local control of translation.

Authors:  Stefan Kindler; Huidong Wang; Dietmar Richter; Henri Tiedge
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

8.  A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P.

Authors:  A Schenck; B Bardoni; A Moro; C Bagni; J L Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 9.  The translation of translational control by FMRP: therapeutic targets for FXS.

Authors:  Jennifer C Darnell; Eric Klann
Journal:  Nat Neurosci       Date:  2013-04-14       Impact factor: 24.884

10.  Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.

Authors:  Edouard W Khandjian; Marc-Etienne Huot; Sandra Tremblay; Laetitia Davidovic; Rachid Mazroui; Barbara Bardoni
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.